Tycel J. Phillips, MD, on Administering Glofitamab Monotherapy to Patients With Mantle Cell Lymphoma

Posted: Thursday, January 5, 2023

Tycel J. Phillips, MD, of the City of Hope National Medical Center, discusses what new findings on glofitamab could mean for outcomes in patients with relapsed or refractory mantle cell lymphoma who have received obinutuzumab pretreatment.